{"title":"Laparoscopic Sleeve Gastrectomy: Efficacy and Safety of Classic vs. Hard Techniques in Long-Term Weight Loss: A Retrospective Cohort Study.","authors":"Oktyabr Ruhullaevich Teshaev, Umid S Ruziyev","doi":"10.17476/jmbs.2025.14.2.150","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to compare the efficacy and safety of Classic and Hard laparoscopic sleeve gastrectomy (LSG) techniques, with a focus on long-term weight loss outcomes and complication rates over a 3-year follow-up period.</p><p><strong>Materials and methods: </strong>A retrospective cohort study was conducted on 785 patients who underwent LSG between January 2019 and December 2022, with follow-up completed by 2023. Patients were divided into 2 groups according to surgical technique: Classic LSG (n=372), involving standard resection along the lesser curvature using a 36-French bougie; and Hard LSG (n=413), characterized by more extensive fundal mobilization and creation of a narrower gastric tube using a 32-French bougie.</p><p><strong>Results: </strong>Both techniques resulted in significant body mass index (BMI) reductions; however, Hard LSG demonstrated superior weight loss. At 12 months, 70.7% of Hard LSG patients achieved a normal BMI (<25 kg/m<sup>2</sup>), compared to 42.2% in the Classic group. At 3 years, 59.3% and 20.4% maintained normal BMI, respectively (P<0.001). However, Hard LSG was associated with higher complication rates: early metabolic complications occurred in 64.3% vs. 25.7% (P<0.001), and late surgical complications in 10.4% vs. 2.4% (P<0.001).</p><p><strong>Conclusion: </strong>While Hard LSG provides greater and more durable weight loss, it is associated with increased risks of complications. These findings support the need for individualized surgical decision-making to balance efficacy and safety in the management of obesity.</p>","PeriodicalId":73828,"journal":{"name":"Journal of metabolic and bariatric surgery","volume":"14 2","pages":"150-156"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411146/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of metabolic and bariatric surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17476/jmbs.2025.14.2.150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: This study aimed to compare the efficacy and safety of Classic and Hard laparoscopic sleeve gastrectomy (LSG) techniques, with a focus on long-term weight loss outcomes and complication rates over a 3-year follow-up period.
Materials and methods: A retrospective cohort study was conducted on 785 patients who underwent LSG between January 2019 and December 2022, with follow-up completed by 2023. Patients were divided into 2 groups according to surgical technique: Classic LSG (n=372), involving standard resection along the lesser curvature using a 36-French bougie; and Hard LSG (n=413), characterized by more extensive fundal mobilization and creation of a narrower gastric tube using a 32-French bougie.
Results: Both techniques resulted in significant body mass index (BMI) reductions; however, Hard LSG demonstrated superior weight loss. At 12 months, 70.7% of Hard LSG patients achieved a normal BMI (<25 kg/m2), compared to 42.2% in the Classic group. At 3 years, 59.3% and 20.4% maintained normal BMI, respectively (P<0.001). However, Hard LSG was associated with higher complication rates: early metabolic complications occurred in 64.3% vs. 25.7% (P<0.001), and late surgical complications in 10.4% vs. 2.4% (P<0.001).
Conclusion: While Hard LSG provides greater and more durable weight loss, it is associated with increased risks of complications. These findings support the need for individualized surgical decision-making to balance efficacy and safety in the management of obesity.